All Articles

A 90-day plan promises cheaper burgers for Americans, but at what cost? We unravel the complex network connecting your plate to the struggling American rancher.

The Chinese lender's net loss explodes by 900%, yet it claims strategic success. A deep dive into the numbers reveals a story of survival amid a property crisis.

A major acquisition in South St. Paul highlights a strategic shift in industrial real estate, leveraging adaptive reuse and rail to meet modern supply chain demands.

With a $1.6M CDC grant, a new alliance seeks to arm patients and providers against Polymyalgia Rheumatica, a debilitating disease affecting up to 800,000 Americans.

With China's new digital labeling rules looming, Hong Kong is leveraging tech and global standards to redefine food safety and build consumer trust.

A new cabless, electric mining truck that drives both ways is here. We explore how EACON's innovation is rewriting the rules of industrial efficiency and safety.

Celebrating a rare 'Multiversary,' Grambling State University takes its 125-year story on the road, showcasing the innovative spirit of HBCUs.

EPTG's acquisition of JBI Technologies isn't just a merger; it's a strategic play for vertical dominance in the rapidly evolving hospitality tech market.

SmallRig's acquisition of Kelvin's lighting assets is more than a simple buyout; it’s a calculated move to build an end-to-end creative ecosystem.

For 41 years, the Buoniconti Fund has blended celebrity power with scientific ambition. Inside the system that turns a father's promise into a global race for a cure.

With its new COVID vaccine approved, Novavax is leveraging global partners like Sanofi to earn royalties, proving an asset-light model can rival industry giants.

Ulike gathered Nobel laureates and wellness advocates in Boston to prove beauty doesn't have to hurt. Is its high-tech, gentle approach the future?

As Labcorp executives prepare for a key fireside chat, investors and industry watchers anticipate insights into AI, personalized medicine, and future growth.

BioLineRx secures crucial funds for its cancer drugs, but at a cost. We dissect the deal, the shareholder dilution, and what it reveals about biotech financing.

A C$48M investment in a Chilean mine isn't just about copper. It’s a masterclass in strategic foresight and a new model for securing future resources.

Procam International acquires and revamps HDOR, blending a virtual fitness challenge with social impact to capture India's billion-user digital market.

A physician-led clinic in Markham is the first in Eastern Canada to adopt Onda Pro, a novel microwave technology. Is this the future of non-invasive aesthetics?

Geely's new Zhanjian 700 boasts floating capabilities and an AI brain. But do these promises hold up under the scrutiny of real-world danger?

After a strategic reset, Australian biopharma Immuron reports record sales and a stronger cash position, pivoting to partner its high-value drug candidates.

A new platform promises to make complex crypto and stock trading as easy as a single tap. But does this radical simplification hide extreme financial risks?